| SN. |
Smith & Nephew
|
FTSE 100 |
2.44 |
£9.71B |
1,147.00 |
0.88% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.47 |
£4.12B |
210.00 |
-0.38% |
| UPR |
Uniphar
|
AIM |
0.00 |
£922.88M |
348.00 |
0.90% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
0.93 |
£656.5M |
164.40 |
0.86% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.16 |
£533.87M |
243.00 |
3.10% |
| NIOX |
Niox Group
|
AIM |
2.23 |
£292.61M |
68.00 |
% |
| TSTL |
Tristel
|
AIM |
3.57 |
£190.53M |
392.00 |
1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£111.93M |
26.70 |
1.00% |
| SPEC |
Inspecs Group
|
AIM |
|
£84.9M |
82.00 |
-0.30% |
| SDI |
SDI Group
|
AIM |
|
£80.3M |
75.74 |
-1.50% |
| KMK |
Kromek Group
|
AIM |
|
£70.42M |
10.50 |
8.70% |
| CREO |
Creo Medical Group
|
AIM |
|
£49.3M |
13.10 |
-0.80% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£25.2M |
30.60 |
0.60% |
| NCYT |
Novacyt SA
|
AIM |
|
£23.25M |
30.33 |
4.20% |
| FAB |
Fusion Antibodies
|
AIM |
|
£17.82M |
14.20 |
25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£16.29M |
36.00 |
-0.40% |
| RUA |
RUA Life Sciences
|
AIM |
|
£12.72M |
20.01 |
-6.90% |
| GENI |
Genincode
|
AIM |
|
£8.66M |
1.21 |
1.40% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.2M |
0.45 |
-2.30% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£2.49M |
0.53 |
-3.80% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.15 |
7.30% |